Fingolimod treatment modulates pparγ and cd36 gene expression in women with multiple sclerosis

HIGHLIGHTS

• who: ufeffVu00e9roniqueufeff ufeffFerret-Senaufeff et al. from the University of Kansas Medical Center, United States have published the article: Fingolimod treatment modulates PPARu03b3 and CD36 gene expression in women with multiple sclerosis, in the Journal: (JOURNAL)
• what: All patients signed informed consent and the study was conducted according to the Declaration of Helsinki and approved by the local Ethics Committees (Central frontiersin.org 10.3389/fnmol.2022.1077381 Lisbon University Hospital Centre and Fernando da Fonseca Hospital). the 6-month and 12-month follow-ups were compared with baseline data through a nonparametric Wilcoxon test . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.